Pantoprazole isomer - Sepracor
Latest Information Update: 24 Oct 2021
At a glance
- Originator Sepracor
- Developer Sunovion Pharmaceuticals
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Antiulcers; Gastric antisecretories; Small molecules
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gastro-oesophageal reflux
Most Recent Events
- 02 Dec 2003 No development reported - Preclinical for Gastro-oesophageal reflux in USA (unspecified route)
- 18 Apr 2001 Preclinical development for Gastro-oesophageal reflux in USA (Unknown route)